Share Print

February 2012 Funding Opportunities

SPOTLIGHTED FUNDING OPPORTUNITY
Siteman Cancer Center Research Development Awards   The SCC invites junior faculty who are SCC members to submit proposals for a one-year $40,000 pilot & feasibility award.  Projects must involve two or more members from different research programs and utilize one or more of the SCC shared resources.  Up to three awards will be funded.

Deadline for abstract submission:  May 1, 2012;  Full application due June 1, 2012.
http://www2.siteman.wustl.edu/grantsubmission/Home.aspx
Contact Christine Nolan cnolan@wustl.edu for additional details.

FOUNDATION OPPORTUNITIES
The James S. McDonald Foundation invites applications in Brain Cancer Research for its 21st Century Research Awards designed to support research projects with a high probability of generating new knowledge and insights. Projects submitted for funding consideration should be at an early, even preliminary stage of development, and should be intended to break new ground or to revisit commonly-held assumptions. A maximum of $450,000 total costs can be requested and the funds can be expended over a minimum of 3 years to a maximum of 6 years. Smaller amounts of money expended over shorter amounts of time may be requested to help investigators pursue pilot projects or test the feasibility of an experimental approach.

Deadline for internal competition:  March 14, 2012
http://internalcompetitions.wustl.edu/ocfr/grants.nsf/d20d347a226ec79c862567ad005a8e33/c8cb6c9fc5aeda708625684100794f62?OpenDocument

Prostate Cancer Foundation Honorable A. David Mazzone Special Challenge Award Research Program 2012.
Challenge Awards support large-scale research projects. Proposals must be from teams capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe. $500,000 per year direct costs only for two years.

Deadline:  March 16, 2012
http://www.pcf.org/site/c.leJRIROrEpH/b.5849007/k.F70A/Open_RFAs.htm

Multiple Myeloma Research Foundation Senior Research Award.  This is an initiative supporting researchers who have more than five years experience in blood cancer research. The goal of this initiative is to accelerate the development of therapeutic approaches for myeloma and may include proposals in basic science or translational research. $100,000 per year including indirect costs for two years.

Deadline:  March 27, 2012
http://www.themmrf.org/research-programs/for-academic-researchers/grant-opportunities.html

American Cancer Society Research Scholar Grant in Cancer Control, Psychosocial and Behavioral Research.
Up to $200,000 in directs per year for 4 years, or $400,000 per year for 5 years if the study is population based.
    AND
American Cancer Society Research Scholar Grant in Basic, Preclinical, Clinical & Epidemiology Research.
Up to $200,000 in directs per year for 4 years. Applicants must have an independent research or faculty position, be within six years of their first independent research or faculty appointment at the time of application, and not already have substantial grant support.

Deadline:  April 1, 2012
http://www.cancer.org/Research/ResearchProgramsFunding/FundingOpportunities/IndexofGrants/ResearchGrantsforIndependentInvestigators/research-scholar-grants

American Cancer Society Postdoctoral Fellowships.  This award is to support the training of researchers who have received a doctoral degree to provide initial funding leading to an independent career in cancer research (including basic, preclinical, clinical, cancer control, psychosocial, behavioral, epidemiology, health services, and health policy research).
Awards are for 3 years with progressive stipends beginning at $44,000, plus $4,000/yr fellowship allowance.

Deadline:  April 2, 2012

NIH & NCI  OPPORTUNITIES
Request for Applications

NCI R33 Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33)
(RFA-CA-12-005)   This FOA solicits grant applications proposing technically innovative feasibility studies focused on the advanced development and validation of cancer-relevant technologies that address issues related to pre-analytical variations in the collection, processing, handling, and storage of biospecimens or their derivatives. The overall goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or their derived samples for downstream molecular analyses.
Application Receipt Date(s): May 21, 2012; September 18, 2012

Program Announcements

NCI R01 Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy
(PA-12-082)  This FOA encourages basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy.
Letter of Intent due date:  May 5, 2012

NCI R21 Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy
(PA-12-083)   The purpose of this Funding Opportunity Announcement (FOA) is to encourage basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN).
Letter of Intent due date:  May 16, 2012

NCI R21 Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities
(PAR-12-094)  NCI  invites grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies, development and testing of new methodologies, secondary data analyses, and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities.
Application Receipt/Submission Date(s): June 20, 2012

NCI U01 Basic Cancer Research in Cancer Health Disparities
(PAR-12-095)  This FOA encourage grant applications from investigators interested in conducting basic, mechanistic research into the biologic/genetic causes of cancer health disparities.
Application Receipt/Submission Date(s): June 20, 2012

NCI R21 Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research
(PAR-12-096)   The purpose of this FOA is to improve the diversity of the NCI-funded research workforce by supporting and recruiting eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from socially, culturally, economically, or educationally disadvantaged backgrounds

Application Receipt/Submission Date(s): June 20, 2012